• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较患者整体严重程度印象和患者整体变化印象评估抑郁、非小细胞肺癌和哮喘测量的重测信度。

Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures.

机构信息

Critical Path Institute, 1730 East River Road, Suite 200, Tucson, AZ, USA.

GlaxoSmithKline, Collegeville, PA, USA.

出版信息

Qual Life Res. 2022 Dec;31(12):3501-3512. doi: 10.1007/s11136-022-03180-5. Epub 2022 Jul 19.

DOI:10.1007/s11136-022-03180-5
PMID:35854060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9587936/
Abstract

PURPOSE

Score reproducibility is an important measurement property of fit-for-purpose patient-reported outcome (PRO) measures. It is commonly assessed via test-retest reliability, and best evaluated with a stable participant sample, which can be challenging to identify in diseases with highly variable symptoms. To provide empirical evidence comparing the retrospective (patient global impression of change [PGIC]) and current state (patient global impression of severity [PGIS]) approaches to identifying a stable subgroup for test-retest analyses, 3 PRO Consortium working groups collected data using both items as anchor measures.

METHODS

The PGIS was completed on Day 1 and Day 8 + 3 for the depression and non-small cell lung cancer (NSCLC) studies, and daily for the asthma study and compared between Day 3 and 10. The PGIC was completed on the final day in each study. Scores were compared using an intraclass correlation coefficient (ICC) for participants who reported "no change" between timepoints for each anchor.

RESULTS

ICCs using the PGIS "no change" group were higher for depression (0.84 vs. 0.74), nighttime asthma (0.95 vs. 0.53) and daytime asthma (0.86 vs. 0.68) compared to the PGIC "no change" group. ICCs were similar for NSCLC (PGIS: 0.87; PGIC: 0.85).

CONCLUSION

When considering anchor measures to identify a stable subgroup for test-retest reliability analyses, current state anchors perform better than retrospective anchors. Researchers should carefully consider the type of anchor selected, the time period covered, and should ensure anchor content is consistent with the target measure concept, as well as inclusion of both current and retrospective anchor measures.

摘要

目的

适用于特定目的的患者报告结局(PRO)测量的评分可重复性是一项重要的测量特性。它通常通过重测信度进行评估,最好在具有稳定参与者样本的情况下进行评估,而在症状高度变化的疾病中,这可能很难确定。为了提供比较回顾性(患者整体印象变化 [PGIC])和当前状态(患者整体印象严重程度 [PGIS])方法以确定用于重测分析的稳定亚组的经验证据,3 个 PRO 联盟工作组使用这两个项目作为锚定测量收集数据。

方法

在抑郁症和非小细胞肺癌(NSCLC)研究中,PGIS 在第 1 天和第 8 天+3 天完成,在哮喘研究中每天完成,并在第 3 天和第 10 天之间进行比较。PGIC 在每个研究的最后一天完成。对于每个锚定点报告在两个时间点之间“无变化”的参与者,使用组内相关系数(ICC)比较分数。

结果

使用 PGIS“无变化”组的 ICC 对于抑郁症(0.84 与 0.74)、夜间哮喘(0.95 与 0.53)和日间哮喘(0.86 与 0.68),高于 PGIC“无变化”组。对于 NSCLC(PGIS:0.87;PGIC:0.85),ICC 相似。

结论

在考虑用于识别重测可靠性分析的稳定亚组的锚定测量时,当前状态的锚定比回顾性的锚定表现更好。研究人员应仔细考虑所选的锚定类型、涵盖的时间段,并应确保锚定内容与目标测量概念一致,以及包括当前和回顾性的锚定测量。

相似文献

1
Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures.比较患者整体严重程度印象和患者整体变化印象评估抑郁、非小细胞肺癌和哮喘测量的重测信度。
Qual Life Res. 2022 Dec;31(12):3501-3512. doi: 10.1007/s11136-022-03180-5. Epub 2022 Jul 19.
2
Memory-Assisted Global Impression of Change (MAGIC).记忆辅助整体变化印象(MAGIC)。
Ther Innov Regul Sci. 2022 May;56(3):454-463. doi: 10.1007/s43441-022-00377-1. Epub 2022 Feb 22.
3
Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures.哮喘日间症状日记(ADSD)和哮喘夜间症状日记(ANSD):新型患者报告症状测量工具的测量特性。
J Allergy Clin Immunol Pract. 2022 May;10(5):1249-1259. doi: 10.1016/j.jaip.2021.11.026. Epub 2021 Dec 8.
4
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial.利用III期EXPLORER-HCM试验的结果对肥厚型心肌病症状问卷(HCMSQ)进行纵向心理测量分析。
Pharmacoecon Open. 2022 Jul;6(4):575-586. doi: 10.1007/s41669-022-00340-8. Epub 2022 Jun 20.
5
Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula.评估患者报告结局测量的重测信度使用组内相关系数:选择和记录分析公式的建议。
Qual Life Res. 2019 Apr;28(4):1029-1033. doi: 10.1007/s11136-018-2076-0. Epub 2018 Dec 13.
6
Clinical meaningfulness and psychometric robustness of the MG Symptoms PRO scales in clinical trials in adults with myasthenia gravis.重症肌无力成年患者临床试验中MG症状PRO量表的临床意义及心理测量稳健性
Front Neurol. 2024 Jun 24;15:1368525. doi: 10.3389/fneur.2024.1368525. eCollection 2024.
7
Reliability and between-group stability of a health-related quality of life symptom index for persons with anal high-grade squamous intraepithelial lesions: an AIDS Malignancy Consortium Study (AMC-A03).肛门高级别鳞状上皮内瘤变患者健康相关生活质量症状指数的可靠性和组间稳定性:艾滋病恶性肿瘤联盟研究(AMC-A03)。
Qual Life Res. 2019 May;28(5):1265-1269. doi: 10.1007/s11136-018-2089-8. Epub 2019 Jan 7.
8
Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.一种用于静脉曲张的新型患者报告结局(PRO)症状日记的心理测量评估:VVSymQ(®) 工具
Patient. 2016 Aug;9(4):335-48. doi: 10.1007/s40271-015-0159-3.
9
Evaluating test-retest reliability in patient-reported outcome measures for older people: A systematic review.评估老年人患者报告结局测量工具的重测信度:系统评价。
Int J Nurs Stud. 2018 Mar;79:58-69. doi: 10.1016/j.ijnurstu.2017.11.003. Epub 2017 Nov 8.
10
Psychometric evaluation of the DAILY EATS questionnaire in individuals living with obesity.肥胖个体每日饮食问卷的心理测量学评估
J Patient Rep Outcomes. 2020 Nov 23;4(1):99. doi: 10.1186/s41687-020-00259-w.

引用本文的文献

1
A Qualitative Study on Patient Experience with Signs, Symptoms, and Daily Impacts of Immune Thrombocytopenia.一项关于免疫性血小板减少症患者体征、症状及日常影响体验的定性研究。
Patient. 2025 Aug 16. doi: 10.1007/s40271-025-00762-6.
2
Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.为急诊医学住院医师实施一项由住院医师主导的新型同伴支持计划。
Behav Sci (Basel). 2025 Jul 12;15(7):943. doi: 10.3390/bs15070943.
3
Psychometric validation of the severity of chronic cough diary, leicester cough questionnaire, and a cough severity visual analogue scale in patients with refractory chronic cough.慢性咳嗽日记严重程度、莱斯特咳嗽问卷及咳嗽严重程度视觉模拟量表在难治性慢性咳嗽患者中的心理测量学验证
J Patient Rep Outcomes. 2025 Jun 11;9(1):65. doi: 10.1186/s41687-025-00888-z.
4
Meaningful Score Differences and Meaningful Score Regions of the Patient-Reported Outcomes Measurement Information System® Pediatric Asthma Impact Scale.患者报告结局测量信息系统®儿童哮喘影响量表的有意义评分差异和有意义评分区域
Value Health. 2025 Jun 5. doi: 10.1016/j.jval.2025.05.010.
5
Myelofibrosis symptom assessment form total symptom score version 4.0: measurement properties from the MOMENTUM phase 3 study.骨髓纤维化症状评估表总症状评分4.0版:来自MOMENTUM 3期研究的测量属性
Qual Life Res. 2025 Mar;34(3):739-750. doi: 10.1007/s11136-024-03855-1. Epub 2024 Nov 25.
6
Patient-reported assessments of chronic cough in clinical trials: accessory or primary endpoints?临床试验中患者报告的慢性咳嗽评估:次要终点还是主要终点?
J Thorac Dis. 2024 Oct 31;16(10):7165-7181. doi: 10.21037/jtd-24-705. Epub 2024 Oct 30.
7
Long-term efficacy and reduced side-effects of buprenorphine in patients with moderate and severe chronic pain.丁丙诺啡对中重度慢性疼痛患者的长期疗效及副作用的减轻
Front Pharmacol. 2024 Aug 8;15:1454601. doi: 10.3389/fphar.2024.1454601. eCollection 2024.
8
UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia.英国医用大麻注册研究:失眠患者的临床疗效评估。
Brain Behav. 2024 Feb;14(2):e3410. doi: 10.1002/brb3.3410.
9
Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial.长期静脉注射Trappsol® Cyclo™(羟丙基-β-环糊精)可使1型尼曼-匹克病患者获得临床益处,并使疾病进展稳定或减缓:一项为期48周的国际I/II期试验结果
Mol Genet Metab Rep. 2023 Jun 29;36:100988. doi: 10.1016/j.ymgmr.2023.100988. eCollection 2023 Sep.
10
Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up.长效舒利迭单抗改善冷凝集素病患者的生活质量:CARDINAL 两年随访。
Blood Adv. 2023 Oct 10;7(19):5890-5897. doi: 10.1182/bloodadvances.2022009318.

本文引用的文献

1
Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures.哮喘日间症状日记(ADSD)和哮喘夜间症状日记(ANSD):新型患者报告症状测量工具的测量特性。
J Allergy Clin Immunol Pract. 2022 May;10(5):1249-1259. doi: 10.1016/j.jaip.2021.11.026. Epub 2021 Dec 8.
2
Non-Small Cell Lung Cancer Symptom Assessment Questionnaire: Psychometric Performance and Regulatory Qualification of a Novel Patient-Reported Symptom Measure.非小细胞肺癌症状评估问卷:一种新型患者报告症状测量方法的心理测量性能和监管资质
Curr Ther Res Clin Exp. 2021 Aug 26;95:100642. doi: 10.1016/j.curtheres.2021.100642. eCollection 2021.
3
Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure.《主要抑郁障碍症状量表》症状:一种新型患者报告症状测量工具的表现。
Value Health. 2019 Aug;22(8):906-915. doi: 10.1016/j.jval.2019.02.010. Epub 2019 May 17.
4
Assessing test-retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula.评估患者报告结局测量的重测信度使用组内相关系数:选择和记录分析公式的建议。
Qual Life Res. 2019 Apr;28(4):1029-1033. doi: 10.1007/s11136-018-2076-0. Epub 2018 Dec 13.
5
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.ISOQOL 建议在以患者为中心的结局和比较效果研究中使用患者报告结局测量,采用最低标准。
Qual Life Res. 2013 Oct;22(8):1889-905. doi: 10.1007/s11136-012-0344-y. Epub 2013 Jan 4.
6
The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims.患者报告结局(PRO)联盟:填补 PRO 终点测量空白,以支持标签声明。
Clin Pharmacol Ther. 2011 Nov;90(5):743-8. doi: 10.1038/clpt.2011.203. Epub 2011 Oct 12.
7
Intraclass correlations: uses in assessing rater reliability.组内相关系数:在评估评分者可靠性中的应用。
Psychol Bull. 1979 Mar;86(2):420-8. doi: 10.1037//0033-2909.86.2.420.
8
Measurement of health status. Ascertaining the minimal clinically important difference.健康状况的测量。确定最小临床重要差异。
Control Clin Trials. 1989 Dec;10(4):407-15. doi: 10.1016/0197-2456(89)90005-6.